Massive study reveals which diabetes drug is best for your heart
NCT ID NCT05214573
Summary
This study analyzed health records of over 380,000 adults with type 2 diabetes to compare four common second-line medications. Researchers wanted to see which drug class—GLP-1RAs, SGLT2is, DPP-4is, or sulfonylureas—was most effective at preventing major heart problems like heart attacks and strokes in people at moderate risk. A unique part of the study also asked patients what treatment outcomes mattered most to them, aiming to make future care more patient-centered.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic Rochester
Rochester, Minnesota, 55905, United States
Conditions
Explore the condition pages connected to this study.